Oncology Data Advisor
The Groundbreaking Approval of Tebentafusp for Uveal Melanoma With Richard Carvajal, MD
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:05:15
- More information
Informações:
Synopsis
In this interview, Dr. Richard Carvajal, Associate Professor of Medicine at Columbia University Irving Medical Center and editorial board member of Oncology Data Advisor, discusses the practice-changing significance of the approval of tebentafusp and delves further into future directions in the development of treatments for uveal melanoma.
